Objective: To assess whether MYH9 mutant alleles linked to hereditary hearing loss induce disruption of cellular functions and associated phenotype following transient expression within cultured human cell lines.
Study Design: Dominantly inherited MYH9 mutant alleles, MYH9R702C and MYH9R705H, were integrated within eukaryotic expression vector and then transfected into cultured human cell lines for transient expression and analysis. The transfected cells were assessed for transgene-induced alterations of the cellular phenotype, including NMHC-IIA-dependent cell shape, actin cytoskeleton integrity, and inhibition of cytokinesis.
Setting: Laboratories of Molecular Otology and Molecular Genetics at the New York University School of Medicine.
Subjects and Methods: HeLa and MDA-MB-231 cultured cell lines were transiently transfected with an expression vector carrying a wild type or mutant MYH9 alleles, linked to nonsyndromic and syndromic hearing loss. Expression of exogenous transgene product was detected with antibodies directed toward its N-terminal HA tag, and transfection efficiency was greater than 95 percent. Host cells were characterized for cell shape, integrity of actin-myosin cytoskeleton, and nuclear status before and after transfections via immunofluorescence.
Results: MDA-MB-231 cells transfected with MYH9R705H but not MYH9R702C were found to have a greater than two-fold increase in cells with filopodia and a ten-fold increase in proportion of cells with multiple nuclei, indicating inhibition of cytokinesis, relative to the control cells transfected with wild type MYH9. Actin cytoskeleton configuration within MDA-MB-231 cells was unaffected by expression of MYH9R702C or MYH9R705H. Unlike MDA-MB-231 cells, HeLa cells were refractory to MYH9R705H and MYH9R702C.
Conclusions: MYH9R705H-induced altered phenotype of the MDA-MB-231 cell line supports the pathogenicity of the mutation and represents a suitable assay system for identification and characterization of its dysfunction.
Get full access to this article
View all access options for this article.
References
1.
. SimonsMWangMMcBrideOW. Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ Res1991;69:530–9.
2.
. ToothakerLEGonzalezDATungN. Cellular myosin heavy chain in human leukocytes: isolation of 5′ cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiation. Blood1991;78:1826–33.
3.
. SellersJR.Myosins: a diverse superfamily. Biochem Biophys Acta2000;1496:3–22.
4.
. HildebrandMSde SilvaMGGardnerRJ. Cochlear implants for DFNA17 deafness. Laryngoscope2006;116:2211–5.
5.
. LalwaniAKGoldsteinJAKelleyMJ. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet2000;67:1121–8.
6.
. ContiMAEven-RamSLiuC. Defects in cell adhesion and the visceral endoderm following ablation of nonmuscle myosin heavy chain II-A in mice. J Biol Chem2004;279:41263–6.
7.
. MhatreANLiYBhatiaN. Generation and characterization of mice with MYH9 deficiency. Neuromolecular Med2007;9:205–15.
8.
. LiYFriedmannDRMhatreAN. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function. Cell Motil Cytoskeleton2008;65:393–405.
9.
. DulyaninovaNGHouseRPBetapudiV. Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells. Mol Biol Cell2007;18:3144–55.
10.
. ZhuravlevPIPapoianGA.Molecular noise of capping protein binding induces macroscopic instability in filopodial dynamics. Proc Natl Acad Sci USA2009;106:11570–5.
